Auriculotherapy for chronic migraine study
Analysis based on 7 articles · First reported Jul 09, 2026 · Last updated Jul 12, 2026
The study is unlikely to have immediate market impact. If confirmed in larger trials, auriculotherapy could become a complementary treatment for migraine, potentially affecting the migraine drug market.
A randomized clinical trial presented at the Federation of European Neuroscience Societies (FENS) Forum 2026 investigated auriculotherapy (ear acupuncture) for chronic migraine. Led by Fernanda Belle of the University of Southern Santa Catarina (UNISUL), Brazil, the study involved 68 women with chronic migraine. Participants received either auriculotherapy or a sham procedure over eight weeks. Both groups reported reduced pain and improved daily function, but no statistically significant difference was found between groups. Researchers observed changes in prefrontal cortex oxygenation via hemoencephalography. The findings are considered preliminary, and larger studies are planned.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard